HEMATOXYLIN
HEMATOXYLIN is a lipid of Polyketides (PK) class. Hematoxylin is associated with abnormalities such as Eosinophilia, Duodenal Adenoma, Senile Plaques, Morphologically altered structure and Cervical abscess. The involved functions are known as Uptake, Apoptosis, Amplification, Necrosis and Karyopyknosis. Hematoxylin often locates in Body tissue, Extracellular, Compact bone, Skin and Basement membrane. The associated genes with HEMATOXYLIN are GAPDH gene, Genome, Elastin, MERTK wt Allele and P4HTM gene.
Cross Reference
Introduction
To understand associated biological information of HEMATOXYLIN, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with HEMATOXYLIN?
HEMATOXYLIN is suspected in Senile Plaques, Eosinophilia, Duodenal Adenoma, Morphologically altered structure, Cervical abscess and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with HEMATOXYLIN
PubChem Associated disorders and diseases
What pathways are associated with HEMATOXYLIN
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with HEMATOXYLIN?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with HEMATOXYLIN?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with HEMATOXYLIN?
There are no associated biomedical information in the current reference collection.
What genes are associated with HEMATOXYLIN?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with HEMATOXYLIN?
There are no associated biomedical information in the current reference collection.
NCBI Entrez Crosslinks
All references with HEMATOXYLIN
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Lu F et al. | Nuclear ING2 expression is reduced in human cutaneous melanomas. | 2006 | Br. J. Cancer | pmid:16755297 |
| GarcÃa-Closas M et al. | Established breast cancer risk factors by clinically important tumour characteristics. | 2006 | Br. J. Cancer | pmid:16755295 |
| Nieto Y et al. | Prognostic analysis of tumour angiogenesis, determined by microvessel density and expression of vascular endothelial growth factor, in high-risk primary breast cancer patients treated with high-dose chemotherapy. | 2007 | Br. J. Cancer | pmid:17609662 |
| Terry G et al. | The role of human papillomavirus type 16 and the fragile histidine triad gene in the outcome of cervical neoplastic lesions. | 2004 | Br. J. Cancer | pmid:15570308 |
| Zaman MS et al. | The functional significance of microRNA-145 in prostate cancer. | 2010 | Br. J. Cancer | pmid:20588276 |
| Hu DE et al. | Early detection of tumour immune-rejection using magnetic resonance imaging. | 2003 | Br. J. Cancer | pmid:12671716 |
| Watson PH et al. | Carbonic anhydrase XII is a marker of good prognosis in invasive breast carcinoma. | 2003 | Br. J. Cancer | pmid:12671706 |
| Zlobec I et al. | Prognostic and predictive value of TOPK stratified by KRAS and BRAF gene alterations in sporadic, hereditary and metastatic colorectal cancer patients. | 2010 | Br. J. Cancer | pmid:19935791 |
| Aaltonen K et al. | Reliability of cyclin A assessment on tissue microarrays in breast cancer compared to conventional histological slides. | 2006 | Br. J. Cancer | pmid:16670718 |
| Unger K et al. | RET rearrangements in post-Chernobyl papillary thyroid carcinomas with a short latency analysed by interphase FISH. | 2006 | Br. J. Cancer | pmid:16641909 |
| Hanly AM et al. | Thrombomodulin expression in colorectal carcinoma is protective and correlates with survival. | 2006 | Br. J. Cancer | pmid:16622452 |
| Grabowski P et al. | Prognostic value of nuclear survivin expression in oesophageal squamous cell carcinoma. | 2003 | Br. J. Cancer | pmid:12556969 |
| Kato K et al. | Effects of green tea polyphenol on methylation status of RECK gene and cancer cell invasion in oral squamous cell carcinoma cells. | 2008 | Br. J. Cancer | pmid:18665171 |
| Stumpf M et al. | Intraepithelial CD8-positive T lymphocytes predict survival for patients with serous stage III ovarian carcinomas: relevance of clonal selection of T lymphocytes. | 2009 | Br. J. Cancer | pmid:19861998 |
| Nam SY et al. | A hypoxia-dependent upregulation of hypoxia-inducible factor-1 by nuclear factor-κB promotes gastric tumour growth and angiogenesis. | 2011 | Br. J. Cancer | pmid:21119667 |
| Lamont FR et al. | Small molecule FGF receptor inhibitors block FGFR-dependent urothelial carcinoma growth in vitro and in vivo. | 2011 | Br. J. Cancer | pmid:21119661 |
| Batistatou A et al. | In breast carcinoma dysadherin expression is correlated with invasiveness but not with E-cadherin. | 2007 | Br. J. Cancer | pmid:17437014 |
| Griffiths EA et al. | Increasing expression of hypoxia-inducible proteins in the Barrett's metaplasia-dysplasia-adenocarcinoma sequence. | 2007 | Br. J. Cancer | pmid:17437013 |
| Palfi S et al. | Correlation of in vitro infiltration with glioma histological type in organotypic brain slices. | 2004 | Br. J. Cancer | pmid:15292940 |
| Hibi K et al. | Methylation pattern of CDH13 gene in digestive tract cancers. | 2004 | Br. J. Cancer | pmid:15292927 |
| Rehman I et al. | S100A6 (Calcyclin) is a prostate basal cell marker absent in prostate cancer and its precursors. | 2004 | Br. J. Cancer | pmid:15280928 |
| Pritchard-Jones RO et al. | Expression of VEGF(xxx)b, the inhibitory isoforms of VEGF, in malignant melanoma. | 2007 | Br. J. Cancer | pmid:17595666 |
| Suzuoki M et al. | Impact of caveolin-1 expression on prognosis of pancreatic ductal adenocarcinoma. | 2002 | Br. J. Cancer | pmid:12402154 |
| Kikuchi R et al. | Nuclear BAG-1 expression reflects malignant potential in colorectal carcinomas. | 2002 | Br. J. Cancer | pmid:12402153 |
| Connolly EM et al. | Cyclo-oxygenase inhibition reduces tumour growth and metastasis in an orthotopic model of breast cancer. | 2002 | Br. J. Cancer | pmid:12107848 |
| McCall P et al. | Phosphorylation of the androgen receptor is associated with reduced survival in hormone-refractory prostate cancer patients. | 2008 | Br. J. Cancer | pmid:18349820 |
| Barnes N et al. | Survivin expression in in situ and invasive breast cancer relates to COX-2 expression and DCIS recurrence. | 2006 | Br. J. Cancer | pmid:16421596 |
| Le Page C et al. | Gene expression profiling of primary cultures of ovarian epithelial cells identifies novel molecular classifiers of ovarian cancer. | 2006 | Br. J. Cancer | pmid:16421595 |
| Hiraoka K et al. | Concurrent infiltration by CD8+ T cells and CD4+ T cells is a favourable prognostic factor in non-small-cell lung carcinoma. | 2006 | Br. J. Cancer | pmid:16421594 |
| Querzoli P et al. | An immunohistochemically positive E-cadherin status is not always predictive for a good prognosis in human breast cancer. | 2010 | Br. J. Cancer | pmid:21063415 |
| Lawson MH et al. | Bcl-2 and β1-integrin predict survival in a tissue microarray of small cell lung cancer. | 2010 | Br. J. Cancer | pmid:21063403 |
| Vizoso FJ et al. | Study of matrix metalloproteinases and their inhibitors in breast cancer. | 2007 | Br. J. Cancer | pmid:17342087 |
| West NP et al. | The proportion of tumour cells is an independent predictor for survival in colorectal cancer patients. | 2010 | Br. J. Cancer | pmid:20407439 |
| Miyazono F et al. | Quantitative c-erbB-2 but not c-erbB-1 mRNA expression is a promising marker to predict minor histopathologic response to neoadjuvant radiochemotherapy in oesophageal cancer. | 2004 | Br. J. Cancer | pmid:15213712 |
| Ebihara Y et al. | DARPP-32 expression arises after a phase of dysplasia in oesophageal squamous cell carcinoma. | 2004 | Br. J. Cancer | pmid:15188007 |
| Julien C et al. | Assessment of vascular reactivity in rat brain glioma by measuring regional blood volume during graded hypoxic hypoxia. | 2004 | Br. J. Cancer | pmid:15188003 |
| Belien JA et al. | Gross genomic damage measured by DNA image cytometry independently predicts gastric cancer patient survival. | 2009 | Br. J. Cancer | pmid:19738619 |
| Qualtrough D et al. | The actin-bundling protein fascin is overexpressed in colorectal adenomas and promotes motility in adenoma cells in vitro. | 2009 | Br. J. Cancer | pmid:19738613 |
| Sigstad E et al. | A prospective study of the relationship between prediagnostic human papillomavirus seropositivity and HPV DNA in subsequent cervical carcinomas. | 2002 | Br. J. Cancer | pmid:12107839 |
| Roche-Nagle G et al. | Antimetastatic activity of a cyclooxygenase-2 inhibitor. | 2004 | Br. J. Cancer | pmid:15213717 |
| Lin HJ et al. | Elevated phosphorylation and activation of PDK-1/AKT pathway in human breast cancer. | 2005 | Br. J. Cancer | pmid:16288304 |
| Hu L et al. | Ovarian cancer stem-like side-population cells are tumourigenic and chemoresistant. | 2010 | Br. J. Cancer | pmid:20354527 |
| Tørring N et al. | Genome-wide analysis of allelic imbalance in prostate cancer using the Affymetrix 50K SNP mapping array. | 2007 | Br. J. Cancer | pmid:17245344 |
| Bjørge L et al. | Ascitic complement system in ovarian cancer. | 2005 | Br. J. Cancer | pmid:15726105 |
| Yokoyama Y and Ramakrishnan S | Improved biological activity of a mutant endostatin containing a single amino-acid substitution. | 2004 | Br. J. Cancer | pmid:15083196 |
| Frei KA et al. | Photodynamic detection of diseased axillary sentinel lymph node after oral application of aminolevulinic acid in patients with breast cancer. | 2004 | Br. J. Cancer | pmid:14970857 |
| Grelier G et al. | Prognostic value of Dicer expression in human breast cancers and association with the mesenchymal phenotype. | 2009 | Br. J. Cancer | pmid:19672267 |
| Lau YS et al. | Malignant melanoma and bone resorption. | 2006 | Br. J. Cancer | pmid:16641914 |
| Boneberg EM et al. | Angiogenesis and lymphangiogenesis are downregulated in primary breast cancer. | 2009 | Br. J. Cancer | pmid:19672262 |
| Beskow C et al. | Radioresistant cervical cancer shows upregulation of the NHEJ proteins DNA-PKcs, Ku70 and Ku86. | 2009 | Br. J. Cancer | pmid:19672258 |
| Al-Yasi AR et al. | Axillary node status in breast cancer patients prior to surgery by imaging with Tc-99m humanised anti-PEM monoclonal antibody, hHMFG1. | 2002 | Br. J. Cancer | pmid:11953817 |
| Mollevà DG et al. | PRL-3 is essentially overexpressed in primary colorectal tumours and associates with tumour aggressiveness. | 2008 | Br. J. Cancer | pmid:19002188 |
| Buffart TE et al. | MAL promoter hypermethylation as a novel prognostic marker in gastric cancer. | 2008 | Br. J. Cancer | pmid:19002170 |
| Knight JF et al. | TEAD1 and c-Cbl are novel prostate basal cell markers that correlate with poor clinical outcome in prostate cancer. | 2008 | Br. J. Cancer | pmid:19002168 |
| Otake M et al. | Selective accumulation of ALA-induced PpIX and photodynamic effect in chemically induced hepatocellular carcinoma. | 2003 | Br. J. Cancer | pmid:12915887 |
| Griffiths RW et al. | Expression of the 5T4 oncofoetal antigen in renal cell carcinoma: a potential target for T-cell-based immunotherapy. | 2005 | Br. J. Cancer | pmid:16222313 |
| Koppert LB et al. | Frequent loss of the AXIN1 locus but absence of AXIN1 gene mutations in adenocarcinomas of the gastro-oesophageal junction with nuclear beta-catenin expression. | 2004 | Br. J. Cancer | pmid:14970870 |
| Al-Saad S et al. | The prognostic impact of NF-kappaB p105, vimentin, E-cadherin and Par6 expression in epithelial and stromal compartment in non-small-cell lung cancer. | 2008 | Br. J. Cancer | pmid:18854838 |
| McCall P et al. | Is PTEN loss associated with clinical outcome measures in human prostate cancer? | 2008 | Br. J. Cancer | pmid:18854827 |
| Brunstein F et al. | Histamine, a vasoactive agent with vascular disrupting potential, improves tumour response by enhancing local drug delivery. | 2006 | Br. J. Cancer | pmid:17106443 |
| Ord JJ et al. | Comparison of hypoxia transcriptome in vitro with in vivo gene expression in human bladder cancer. | 2005 | Br. J. Cancer | pmid:16052224 |
| Mellor HR et al. | A model of quiescent tumour microregions for evaluating multicellular resistance to chemotherapeutic drugs. | 2005 | Br. J. Cancer | pmid:16052217 |
| Kusakari T et al. | C-erbB-2 or mutant Ha-ras induced malignant transformation of immortalized human ovarian surface epithelial cells in vitro. | 2003 | Br. J. Cancer | pmid:14676809 |
| Leonard P et al. | Gene expression array profile of human osteosarcoma. | 2003 | Br. J. Cancer | pmid:14676807 |
| Lo Muzio L et al. | Survivin expression in oral squamous cell carcinoma. | 2003 | Br. J. Cancer | pmid:14676801 |
| Wu F et al. | A randomised clinical trial of high-intensity focused ultrasound ablation for the treatment of patients with localised breast cancer. | 2003 | Br. J. Cancer | pmid:14676799 |
| Jamieson SM et al. | Paclitaxel induces nucleolar enlargement in dorsal root ganglion neurons in vivo reducing oxaliplatin toxicity. | 2003 | Br. J. Cancer | pmid:12799641 |
| Duncan R et al. | Characterisation and protein expression profiling of annexins in colorectal cancer. | 2008 | Br. J. Cancer | pmid:18071363 |
| Loussouarn D et al. | Validation of UBE2C protein as a prognostic marker in node-positive breast cancer. | 2009 | Br. J. Cancer | pmid:19513072 |
| Klevesath MB et al. | The value of immunohistochemistry in sentinel lymph node histopathology in breast cancer. | 2005 | Br. J. Cancer | pmid:15942633 |
| Charalambous MP et al. | Expression of COX-2, NF-kappaB-p65, NF-kappaB-p50 and IKKalpha in malignant and adjacent normal human colorectal tissue. | 2009 | Br. J. Cancer | pmid:19513071 |
| Atkin GK et al. | The impact of surgically induced ischaemia on protein levels in patients undergoing rectal cancer surgery. | 2006 | Br. J. Cancer | pmid:17016487 |
| Matsubara J et al. | Impacts of excision repair cross-complementing gene 1 (ERCC1), dihydropyrimidine dehydrogenase, and epidermal growth factor receptor on the outcomes of patients with advanced gastric cancer. | 2008 | Br. J. Cancer | pmid:18231104 |
| Tonini G et al. | Nuclear and cytoplasmic expression of survivin in 67 surgically resected pancreatic cancer patients. | 2005 | Br. J. Cancer | pmid:15928668 |
| Donnelly ET et al. | Metallothionein crypt-restricted immunopositivity indices (MTCRII) correlate with aberrant crypt foci (ACF) in mouse colon. | 2005 | Br. J. Cancer | pmid:15928667 |
| Nakakubo Y et al. | Clinical significance of immune cell infiltration within gallbladder cancer. | 2003 | Br. J. Cancer | pmid:14583778 |
| Doak SH et al. | Characterisation of p53 status at the gene, chromosomal and protein levels in oesophageal adenocarcinoma. | 2003 | Br. J. Cancer | pmid:14583777 |
| Radny P et al. | Phase II trial of intralesional therapy with interleukin-2 in soft-tissue melanoma metastases. | 2003 | Br. J. Cancer | pmid:14583759 |
| Brown MD et al. | Promotion of prostatic metastatic migration towards human bone marrow stoma by Omega 6 and its inhibition by Omega 3 PUFAs. | 2006 | Br. J. Cancer | pmid:16523199 |
| Youssef MM et al. | EMAP-II-dependent lymphocyte killing is associated with hypoxia in colorectal cancer. | 2006 | Br. J. Cancer | pmid:16929248 |
| Bussolati G et al. | A modified Trastuzumab antibody for the immunohistochemical detection of HER-2 overexpression in breast cancer. | 2005 | Br. J. Cancer | pmid:15812476 |
| Liu W et al. | Effects of overexpression of ephrin-B2 on tumour growth in human colorectal cancer. | 2004 | Br. J. Cancer | pmid:15083195 |
| Bugat R et al. | Summary of the Standards, Options and Recommendations for the management of patients with carcinoma of unknown primary site (2002). | 2003 | Br. J. Cancer | pmid:12915904 |
| Villers A et al. | Summary of the Standards, Options and Recommendations for the management of patients with nonmetastatic prostate cancer (2001). | 2003 | Br. J. Cancer | pmid:12915903 |
| Maruyama T et al. | Inverse correlation of HER2 with MHC class I expression on oesophageal squamous cell carcinoma. | 2010 | Br. J. Cancer | pmid:20628381 |
| Polterauer S et al. | The impact of lymph node density on survival of cervical cancer patients. | 2010 | Br. J. Cancer | pmid:20628380 |
| Saeb-Parsy K et al. | MT1-MMP regulates urothelial cell invasion via transcriptional regulation of Dickkopf-3. | 2008 | Br. J. Cancer | pmid:18665176 |
| Caldwell GM et al. | Wnt signalling in adenomas of familial adenomatous polyposis patients. | 2010 | Br. J. Cancer | pmid:20628379 |
| Yoshino H et al. | The tumour-suppressive function of miR-1 and miR-133a targeting TAGLN2 in bladder cancer. | 2011 | Br. J. Cancer | pmid:21304530 |
| Schimanski CC et al. | Dissemination of hepatocellular carcinoma is mediated via chemokine receptor CXCR4. | 2006 | Br. J. Cancer | pmid:16819541 |
| Van Laere SJ et al. | NF-kappaB activation in inflammatory breast cancer is associated with oestrogen receptor downregulation, secondary to EGFR and/or ErbB2 overexpression and MAPK hyperactivation. | 2007 | Br. J. Cancer | pmid:17700572 |
| Bach SP et al. | Regional localisation of p53-independent apoptosis determines toxicity to 5-fluorouracil and pyrrolidinedithiocarbamate in the murine gut. | 2006 | Br. J. Cancer | pmid:16804527 |
| Kato T et al. | The combination of angiogenesis and blood vessel invasion as a prognostic indicator in primary breast cancer. | 2003 | Br. J. Cancer | pmid:12799634 |
| Yoshimoto M et al. | FISH analysis of 107 prostate cancers shows that PTEN genomic deletion is associated with poor clinical outcome. | 2007 | Br. J. Cancer | pmid:17700571 |
| Blancato J et al. | Correlation of amplification and overexpression of the c-myc oncogene in high-grade breast cancer: FISH, in situ hybridisation and immunohistochemical analyses. | 2004 | Br. J. Cancer | pmid:15083194 |
| Arrieta O et al. | Expression of AT1 and AT2 angiotensin receptors in astrocytomas is associated with poor prognosis. | 2008 | Br. J. Cancer | pmid:18594540 |
| Koivunen JP et al. | Mutations in the LKB1 tumour suppressor are frequently detected in tumours from Caucasian but not Asian lung cancer patients. | 2008 | Br. J. Cancer | pmid:18594528 |
| Gisselsson D et al. | Centrosomal abnormalities, multipolar mitoses, and chromosomal instability in head and neck tumours with dysfunctional telomeres. | 2002 | Br. J. Cancer | pmid:12107843 |
| Attard G et al. | Heterogeneity and clinical significance of ETV1 translocations in human prostate cancer. | 2008 | Br. J. Cancer | pmid:18594527 |
| Nomura S et al. | FGF10/FGFR2 signal induces cell migration and invasion in pancreatic cancer. | 2008 | Br. J. Cancer | pmid:18594526 |